Effects of a Paediatric Antimicrobial Stewardship Program on Antimicrobial Use and Quality of Prescriptions in

Sílvia Simó1,2, Eneritz Velasco-Arnaiz1, María Ríos-Barnés1

  • 1Infectious Diseases and Systemic Inflammatory Response in Paediatrics, Infectious Diseases Unit, Department of Paediatrics, Sant Joan de Déu Hospital Research Foundation, 08950 Barcelona, Spain.

Insights

Antimicrobial stewardship programs (ASP) reduced broad-spectrum antimicrobial use and length of therapy for phlegmonous appendicitis in children. The interventions were safe and improved prescription quality without increasing overall antimicrobial use or length of stay.

Area of Science:

  • Pediatric Infectious Diseases
  • Antimicrobial Stewardship
  • Health Services Research

Background:

  • Antimicrobial stewardship programs (ASP) are effective in reducing antimicrobial use (AU).
  • Surgical wards are potential areas for ASP intervention.
  • Appendix-related intraabdominal infections (AR-IAI) are common in children.

Purpose of the Study:

  • To evaluate the impact of an ASP on AU and length of stay (LOS) in pediatric patients with AR-IAI.
  • To assess changes in antimicrobial prescription quality (QP) post-ASP implementation.

Main Methods:

  • Pre-post study design (2014-2016 vs. 2017-2019) at a European pediatric university hospital.
  • ASP intervention based on postprescription review with feedback.
  • Analysis of antimicrobial use (DOT/100PD, LOT), LOS, QP, readmissions, and case fatality rates in 2021 AR-IAI admissions.

Main Results:

  • Global AU and LOS remained unchanged.
  • Significant decrease in LOS and LOT for phlegmonous appendicitis (p=0.003 and p<0.001, respectively).
  • 96% reduction in piperacillin-tazobactam use (p=0.044) with no rebound in other broad-spectrum agents.
  • Quasisignificant increase in QP (p=0.052).

Conclusions:

  • ASP interventions were safe and effective in reducing specific antimicrobial use and improving outcomes for phlegmonous appendicitis in children.
  • ASP implementation led to reduced length of therapy and improved prescription quality.
  • The study demonstrates the benefit of ASP in pediatric surgical infections.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
109
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
107
Appendicitis-II: Diagnostic Studies and Management01:29

Appendicitis-II: Diagnostic Studies and Management

Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
270
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
82
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
120
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.4K